186
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Trend of tuberculosis case notifications and their determinants in Africa and South-East Asia during 2000–2018: a longitudinal analysis of national data from 58 countries

ORCID Icon, , , &
Pages 538-546 | Received 25 Jan 2020, Accepted 22 Apr 2020, Published online: 20 May 2020

References

  • World Health Organization. Global tuberculosis report 2019. Geneva; 2019. https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf? Accessed 20 Oct 2019.
  • Dye C, Williams BG. Eliminating human tuberculosis in the twenty-first century. J R Soc Interface. 2008;5(23):653–662.
  • World Health Organization. The End TB Strategy: global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva; 2014.
  • World Health Organization. Global Tuberculosis Control: surveillance, planning, financing. WHO report 2005. Geneva: WHO; 2005. https://apps.who.int/iris/bitstream/handle/10665/144569/9241562919_eng.pdf. Accessed 25 Jan 2018.
  • Santos ML, Coeli CM, Batista JDL, et al. de FPM de. Fatores associados à subnotificação de tuberculose com base no Sinan Aids e Sinan Tuberculose. Rev Bras Epidemiol. 2018;21:E180019.
  • Satyanarayana S, Nair SA, Chadha SS, et al. From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts. PLoS One. 2011;6(9):e24160.
  • Narasimhan P, Wood J, Macintyre CR, et al. Risk factors for tuberculosis. Pulm Med. 2013;2013:1–11.
  • Duarte R, Lönnroth K, Carvalho C, et al. Tuberculosis, social determinants and co-morbidities (including HIV). Pulmonology. 2018;24(2):115–119.
  • Lönnroth K, Jaramillo E, Williams BG, et al. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009;68(12):2240–2246.
  • World Bank Group. World Development Indicators. 2019. https://data.worldbank.org/indicator/. Accessed 18 Nov 2019.
  • UNAIDS. UNAIDS Estimates 2019: Global AIDS Monitoring 2019. 2019. http://aidsinfo.unaids.org/. Accessed 14 Nov 2019.
  • World Health Organization. Diabetes country profiles 2016; 2016. https://www.who.int/diabetes/country-profiles/en/. Accessed 11 Dec 2019.
  • World Health Organization. Vaccine-preventable diseases: monitoring system 2018 summary; 2018. www.who.int/immunization_monitoring/globalsummary/timeseries. Accessed 30 May 2018.
  • Uplekar M, Atre S, Wells WA, et al. Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice. Eur Respir J. 2016;48(6):1571–1581.
  • Morishita F, Furphy VB, Kobayashi M, et al. Tuberculosis case-finding in Cambodia: analysis of case notification data, 2000 to 2013. WPSAR. 2015;6(1):15–24.
  • Adejumo OA, Daniel OJ, Abdur-Razzaq HA, et al. Trend of tuberculosis case notification and treatment outcome in Lagos State, Nigeria: a 5-year retrospective study. Trans R Soc Trop Med Hyg. 2017;111(7):300–307.
  • Kurhasani X, Hafizi H, Toci E, et al. Tuberculosis incidence and case notification rates in Kosovo and the Balkans in 2012: cross-country comparison. Mater Sociomed. 2014;26(1):55.
  • Dye C, Williams BG. Tuberculosis decline in populations affected by HIV: a retrospective study of 12 countries in the WHO African Region. Bull World Health Organ. 2019;97(6):405–414.
  • Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis. Arch Intern Med. 2003;163(9):1009.
  • Wood R, D. Lawn S. Antiretroviral treatment as prevention: impact of the “Test and Treat” strategy on the tuberculosis epidemic. CHR. 2011;9(6):383–392.
  • Waaler HT. Tuberculosis and poverty. Int J Tuberc Lung Dis. 2002;6(9):745–746.
  • Squire SB, Tang S. How much of China’s success in tuberculosis control is really due to DOTS? Lancet. 2004;364(9432):391–392.
  • Coker R, McKee M, Atun R, et al. Risk factors for pulmonary tuberculosis in Russia: case-control study. Br Med J. 2006;332(7533):85–87.
  • Munch Z, Van Lill SW, Booysen CN, et al. Tuberculosis transmission patterns in a high-incidence area. Int J Tuberc Lung Dis. 2014;7:271–277.
  • Lienhardt C, Fielding K, Sillah J, et al. Investigation of the risk factors for tuberculosis: a case–control study in three countries in West Africa. Int J Epidemiol. 2005;34(4):914–923.
  • Shetty N, Shemko M, Vaz M, et al. An epidemiological evaluation of risk factors for tuberculosis in South India : a matched case control study. Int J Tuberc Lung Dis. 2005;10:80–86.
  • Munayco CV, Mújica OJ, León FX, et al. Social determinants and inequalities in tuberculosis incidence in Latin America and the Caribbean. Pan Am J Public Heal. 2015;2012:177–185.
  • Oxlade O, Schwartzman K, Behr MA, et al. Global tuberculosis trends: a reflection of changes in tuberculosis control or in population health?. Int J Tuberc Lung Dis. 2009;13:1238–1246.
  • Lawn SD, Wood R, De Cock KM, et al. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis. 2010;10(7):489–498.
  • Pendse R, Gupta S, Yu D, et al. HIV/AIDS in the South-East Asia region: progress and challenges. J Virus Erad. 2016. 2( Suppl 4):1–6. http://www.ncbi.nlm.nih.gov/pubmed/28303199%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5353351
  • Harries AD, Zachariah R, Corbett EL, et al. The HIV-associated tuberculosis epidemic-when will we act? Lancet. 2010;375(9729):1906–1919.
  • Kranzer K, van Schaik N, Karmue U, et al. High prevalence of self-reported undiagnosed HIV despite high coverage of HIV testing: a cross-sectional population based sero-survey in South Africa. PLoS One. 2011;6(9):e25244.
  • Staveteig S, Croft TN, Kampa KT, et al. Reaching the ‘first 90’: gaps in coverage of HIV testing among people living with HIV in 16 African countries. PLoS One. 2017;12(10):e0186316–16.
  • Lawn SD, Wood R. Incidence of tuberculosis during highly active antiretroviral therapy in high-income and low-income countries. Clin Infect Dis. 2005;41(12):1783–1786.
  • Dodd PJ, Knight GM, Lawn SD, et al. Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis. PLoS One. 2013;8(9):e75466.
  • Suárez PG, Watt CJ, Alarcón E, et al. The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. J Infect Dis. 2001;184(4):473–478.
  • Balakrishnan S, Vijayan S, Nair S, et al. High diabetes prevalence among tuberculosis cases in Kerala. India PLoS One. 2012;7(10):e46502.
  • Lönnroth K, Williams BG, Cegielski P, et al. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol. 2010;39(1):149–155.
  • Goldhaber-Fiebert JD, Jeon CY, Cohen T, et al. Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants. Int J Epidemiol. 2011;40(2):417–428.
  • Bou JC, Satorra A. Univariate versus multivariate modeling of panel data. Organ Res Methods. 2018;21(1):150–196.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.